Showing results (181-190 of 189) with videos related to
Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Scientific Reports|October 3, 2022
Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancerTomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, et al.Breast Cancer Research and Treatment|March 30, 2021
Low RAI2 expression is a marker of poor prognosis in breast cancerSayaka Nishikawa, Yasuaki Uemoto, Tae-Sun Kim, et al.General Thoracic and Cardiovascular Surgery|February 19, 2025
Guidelines for the treatment of empyema (The Japanese Association for Chest Surgery)Yuji Shiraishi, Mitsugu Omasa, Shinichi Yamashita, et al.Asia-Pacific Journal of Clinical Oncology|April 29, 2024
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patientsYoshihiko Tasaki, Nanami Ito, Yoshihisa Mimura, et al.Translational Lung Cancer Research|March 15, 2021
Comprehensive genomic profiling of combined small cell lung cancerJing Zhang, Liping Zhang, Jie Luo, et al.Translational Lung Cancer Research|January 13, 2023
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohortZihua Zou, Yangchun Gu, Li Liang, et al.Cancer Medicine|November 21, 2023
Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary studyYoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto, et al.Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracyEmina Torlakovic, Hyun J Lim, Julien Adam, et al.Pageof 19